TD Cowen Cuts Schrodinger (NASDAQ:SDGR) Price Target to $24.00

Schrodinger (NASDAQ:SDGR) had its price objective lowered by TD Cowen from $33.00 to $24.00 in a research report report published on Thursday morning,Benzinga reports. TD Cowen currently has a buy rating on the stock.

SDGR has been the subject of several other research reports. Cowen reissued a “buy” rating on shares of Schrodinger in a report on Thursday. The Goldman Sachs Group started coverage on shares of Schrodinger in a research report on Monday, September 29th. They issued a “neutral” rating and a $19.00 price objective for the company. KeyCorp lowered their target price on shares of Schrodinger from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday. Wall Street Zen upgraded shares of Schrodinger from a “sell” rating to a “hold” rating in a research note on Saturday, October 25th. Finally, Bank of America raised shares of Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price target for the company in a report on Monday, December 15th. Six investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Schrodinger currently has a consensus rating of “Hold” and an average target price of $24.33.

Schrodinger Stock Down 1.2%

NASDAQ:SDGR opened at $18.39 on Thursday. The stock has a market capitalization of $1.35 billion, a price-to-earnings ratio of -7.63 and a beta of 1.54. Schrodinger has a 52 week low of $15.99 and a 52 week high of $28.47. The firm has a 50 day moving average of $17.98 and a 200 day moving average of $19.48.

Schrodinger (NASDAQ:SDGR) last issued its quarterly earnings results on Wednesday, November 5th. The company reported ($0.45) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.72) by $0.27. Schrodinger had a negative return on equity of 48.24% and a negative net margin of 68.49%.The business had revenue of $54.32 million for the quarter, compared to the consensus estimate of $50.51 million. During the same period in the prior year, the firm posted ($0.87) earnings per share. The business’s quarterly revenue was up 53.9% on a year-over-year basis. As a group, analysts expect that Schrodinger will post -2.37 EPS for the current year.

Insider Activity at Schrodinger

In other news, insider Margaret Dugan sold 1,395 shares of the stock in a transaction on Thursday, October 16th. The shares were sold at an average price of $21.07, for a total value of $29,392.65. Following the sale, the insider owned 24,574 shares in the company, valued at $517,774.18. This represents a 5.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 21.00% of the stock is owned by company insiders.

Institutional Investors Weigh In On Schrodinger

Several hedge funds have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC raised its stake in shares of Schrodinger by 347.4% during the 2nd quarter. Farther Finance Advisors LLC now owns 1,284 shares of the company’s stock worth $26,000 after buying an additional 997 shares during the period. Bayforest Capital Ltd purchased a new stake in Schrodinger in the 2nd quarter worth $30,000. Aster Capital Management DIFC Ltd raised its position in Schrodinger by 212.4% during the third quarter. Aster Capital Management DIFC Ltd now owns 1,943 shares of the company’s stock worth $39,000 after acquiring an additional 1,321 shares during the period. State of Wyoming purchased a new position in Schrodinger during the second quarter valued at $39,000. Finally, SBI Securities Co. Ltd. lifted its holdings in Schrodinger by 110.4% during the third quarter. SBI Securities Co. Ltd. now owns 2,127 shares of the company’s stock valued at $43,000 after purchasing an additional 1,116 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Key Schrodinger News

Here are the key news stories impacting Schrodinger this week:

• Positive Sentiment: Schrödinger announced a partnership with Eli Lilly to integrate Lilly’s TuneLab AI drug‑discovery platform into Schrödinger’s LiveDesign enterprise informatics platform, making TuneLab a priority interface for participating biotech customers — this strengthens LiveDesign’s product value and could accelerate commercial deals or usage-based revenue. Business Wire
• Positive Sentiment: Media coverage highlights Lilly’s broader pact (including Revvity) to provide AI-driven drug‑discovery capabilities — public attention and third‑party ecosystem involvement can increase demand for Schrödinger’s software interfaces and partnerships. MSN
• Neutral Sentiment: TD Cowen reduced its price target from $33 to $24 but maintained a “buy” rating — this narrows analyst-implied upside while still signaling confidence in long‑term growth potential. TickerReport
• Neutral Sentiment: KeyCorp lowered its target from $28 to $25 and kept an “overweight” rating — another mixed signal: lower near‑term targets but continued positive stance on the business model. TickerReport
• Neutral Sentiment: Market commentary comparing Schrodinger with peers appears, but offers limited incremental near‑term impact; useful for relative valuation context. American Banking News
• Negative Sentiment: UBS initiated coverage with a “hold” and a $18 price target (below recent levels), which could exert downward pressure or limit buying interest until catalysts justify re‑rating. MSN

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.